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Purpose/Objective: Brachytherapy is the cornerstone of 
radiotherapy treatment in cervical cancer. In the last decade 
an increasing number of publications based on single 
institution large series indicate MR based IGABT as the new 
gold standard of treatment allowing a dramatic decrease of 
morbidity and at the same time an increase in local control 
especially for large tumors. Hereby we describe preliminary 
dosimetric results of MR IGABT at our institution. 
Materials and Methods: Since December 2012, 71 
consecutive patients (median age 50,5; range 31- 88,5) with 
a histologically proven diagnosis of locally advanced cervical 
cancer have been referred to GYN tumor board at our 
Institution.  
FIGO stage distribution was the following: 5 had Ib1, 4 had 
Ib2, 1 had IIA, 28 had IIB with mid proximal parametrial 
invasion, 12 had IIB with distal parametrial invasion, 1 had 
IIIA, 13 had IIIB (11 because pelvic wall invasion), 7 had IVA 
cancers. All cases were Diagnostic routine for all patients 
consisted in thorax and abdomen CT and pelvic MR. PET CT 
was obtained in selected cases. All patients had laparoscopic 
retroperitoneal lymphadenectomy. All patients received 
radio-chemotherapy consisting 3DCRT (45 Gy in 25 fr.) 
concomitant to chemotherapy (weekly cisplatin 40 mg m2) 
followed by 4 fraction of 7 Gy each within two different BT 
insertions. Median overall treatment time was 43 days. 2-3 
days before 1 BT implant all patients had a T2 MR scan to 
define tumor regression during radio-chemotherapy. All BT 
applications were performed under spinal anesthesia with 
TRUS and trans-abdominal US guidance. We used MR 
compatible Tandem Ovoids applicators (Elekta Utercht type) 
or Tandem Ring applicator (Elekta Vienna type) with either 
plastic or titanium needles if needed. At first application all 
patients had an MR with the applicator in place and a i.v. 
contrasted CT. A direct reconstruction approach based on 
applicator library or template was used to reconstruct 
applicators on MR images. Target volumes and OAR were 
contoured on MR according GEC ESTRO reccomendations. In 
all cases we started the planning process with a standard 
point A plan which was subsequently modified in order to 
reach our planning aims that are the following: HRCTV 
D9086Gy EQD2, Bladder D2cc<90 Gy EQD2, Rectum and 
Sigmoid bowel D2cc<70 GyEQD2. In the present study we 
report DVH comparison between Standard and optimized 
plans. 
Results: Preliminary dosimetric results are summarized in fig. 
1. At the present moment we had 2 patients with persistent 
disease after BT. Both cases were large IIIB tumors with 
infiltrative growth pattern and received a D90 dose of 85,21 
and 85,51 Gy EQD2 respectively. No intraoperative or 
perioperative events have been registered so far. 
Conclusions: In our preliminary experience MR based IGABT 
is strikingly superior to standard treatment. 
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Purpose/Objective: Image-Guided brachytherapy (IGBT) is 
related to treatment based on the 3D imaging for the 
planning procedure, not for the evaluation of the precision 
and accuracy of the treatment, which is the goal of the 
Image-Guided radiotherapy (IGRT). The aim of this study was 
assessment of probable intra-fractional organ displacement 
after the 3D imaging of the planning purpose.  
Materials and Methods: Thirty intracavitary bracytherapy 
insertions (with Rotterdam's tandem and ovoid applicators) of 
cervical cancer patients were studied. A CT scanning were 
done for each of the cases, for treatment planning, after the 
applicator insertion. Treatment planning was based on 
getting 80-90 Gy total dose to D90 of the HR-CTV (EQD2) and 
70Gy and 80Gy for rectum and bladder (D2cc), respectively. 
For each of those insertions a second CT scan were 
performed for the patients, just after the finishing of her 
treatment and before the applicators removed from her 
body. The scanning protocols (e.g. the amount of normal 
saline injection to the bladder Foley) were the same as the 
first CT imaging. Organ contouring and applicators 
reconstructions were performed with the same physician and 
physicist. The first 3D treatment planning were copied 
